Evidence map›Paper›PMID 40001449›Full record

ArticleAntibiotics (Basel, Switzerland)2025

Genomic Insights into Colistin and Tigecycline Resistance in ESBL-Producing

David Ortega-Paredes, Felipe Del Canto, Rafael Rios, Lorena Diaz, Jinnethe Reyes, Cesar A Arias, Jeannete Zurita

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

David Ortega-ParedesFacultad de Ciencias Médicas Enrique Ortega Moreira, Carrera de Medicina, Universidad Espíritu Santo, Samborondón 092301, Ecuador.
Felipe Del CantoPrograma de Microbiología y Micología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago 9170022, Chile.ORCID 0000-0001-5912-0283
Rafael RiosMolecular Genetics and Antimicrobial Resistance Unit, International Center for Bacterial Genomics, Universidad El Bosque, Bogotá 111321, Colombia.
Lorena DiazMolecular Genetics and Antimicrobial Resistance Unit, International Center for Bacterial Genomics, Universidad El Bosque, Bogotá 111321, Colombia.
Jinnethe ReyesMolecular Genetics and Antimicrobial Resistance Unit, International Center for Bacterial Genomics, Universidad El Bosque, Bogotá 111321, Colombia.
Cesar A AriasMolecular Genetics and Antimicrobial Resistance Unit, International Center for Bacterial Genomics, Universidad El Bosque, Bogotá 111321, Colombia.
Jeannete ZuritaUnidad de Investigaciones en Biomedicina, Zurita & Zurita Laboratorios, Quito 170104, Ecuador.

Funding

Unidad de Investigaciones en Biomedicina, Zurita & Zurita Laboratorios, MIC-02
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

blaKPCcolistin resistanceEcuadorEscherichia coliKlebsiella pneumoniaemcr-1tigecycline resistance

Identifiers

PMID40001449
PMCPMC11851850

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.